Literature DB >> 8354737

A predictive study of obsessive-compulsive disorder response to clomipramine.

R D Alarcon1, J W Libb, D Spitler.   

Abstract

Studies on predictive factors of the obsessive-compulsive disorder response to pharmacologic treatment, specifically clomipramine, are relatively scarce. Forty-five patients treated for a mean period of 18.6 months were classified as having poor response, intermediate response and excellent response, defined by change scores on the Yale-Brown Obsessive-Compulsive Scale. Poor and intermediate response patients were grouped together and compared with the excellent response subgroup. Univariate analysis showed length of illness, family history (siblings), initial compulsiveness score, and cleaning rituals as significant predictors. Two multiple regression analyses with these as independent or predictive variables showed higher initial scores on the Yale-Brown Obsessive-Compulsive Scale associated with poorer response to treatment but, most importantly, cleaning rituals as a predictor of poor or modest response to clomipramine. It may be important for the clinician to assess cleaning habits separately from the more frequently mentioned obsessive-compulsive symptom, hand washing. This distinction may have important clinical, therapeutic, and prognostic implications.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8354737

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  11 in total

Review 1.  Obsessive compulsive disorder.

Authors:  G Mustafa Soomro
Journal:  BMJ Clin Evid       Date:  2012-01-18

Review 2.  Obsessive-compulsive disorder: Insights from animal models.

Authors:  Henry Szechtman; Susanne E Ahmari; Richard J Beninger; David Eilam; Brian H Harvey; Henriette Edemann-Callesen; Christine Winter
Journal:  Neurosci Biobehav Rev       Date:  2016-05-07       Impact factor: 8.989

3.  Obsessive-compulsive disorder for ICD-11: proposed changes to the diagnostic guidelines and specifiers.

Authors:  Helen Blair Simpson; Y C Janardhan Reddy
Journal:  Braz J Psychiatry       Date:  2014       Impact factor: 2.697

4.  Exposure and response prevention helps adults with obsessive-compulsive disorder who do not respond to pharmacological augmentation strategies.

Authors:  Carmen P McLean; Laurie J Zandberg; Page E Van Meter; Joseph K Carpenter; Helen Blair Simpson; Edna B Foa
Journal:  J Clin Psychiatry       Date:  2015-12       Impact factor: 4.384

5.  A 5-year course of predominantly obsessive vs. mixed subtypes of obsessive-compulsive disorder.

Authors:  S B Math; Jaideep Thoduguli; Y C Janardhan Reddy; P N Manoj; A Zutshi; R P Rajkumar; A M Adarsh
Journal:  Indian J Psychiatry       Date:  2007-10       Impact factor: 1.759

6.  An Atypical and Resistant Case of Obsessive Compulsive Disorder Responding Satisfactorily with an Unusual way of Exposure and Response Prevention Therapy.

Authors:  Kamal Nath; Robin Victor; Subrata Naskar
Journal:  J Clin Diagn Res       Date:  2016-03-01

7.  Clinical predictors of drug response in patients with obsessive-compulsive disorder.

Authors:  Chan-Hyung Kim; Jae-Wook Jeong; Eun Ju Kim; Yoon Shick Shin; Ho Suk Suh; Hong Shick Lee; Min-Seong Koo
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-04-30       Impact factor: 2.582

8.  Novel ensemble method for the prediction of response to fluvoxamine treatment of obsessive-compulsive disorder.

Authors:  Hesam Hasanpour; Ramak Ghavamizadeh Meibodi; Keivan Navi; Sareh Asadi
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-10       Impact factor: 2.570

9.  Fluvoxamine treatment response prediction in obsessive-compulsive disorder: association rule mining approach.

Authors:  Hesam Hasanpour; Ramak Ghavamizadeh Meibodi; Keivan Navi; Jamal Shams; Sareh Asadi; Abolhassan Ahmadiani
Journal:  Neuropsychiatr Dis Treat       Date:  2019-04-10       Impact factor: 2.570

10.  Sequential allocation to balance prognostic factors in a psychiatric clinical trial.

Authors:  Victor Fossaluza; Juliana Belo Diniz; Basilio de Bragança Pereira; Eurípedes Constantino Miguel; Carlos Alberto de Bragança Pereira
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.